Safety and Effectiveness of Ramucirumab in Patients with Advanced Gastric CancerStatus: open
Safety and Effectiveness of Ramucirumab in Patients with Advanced Gastric Cancer in European Union and North America: A prospective Observational Registry.
Treatment for Gastric (Stomach) Cancer
Inclusion Criteria: Advanced gastric cancer or GEJ adenocarcinoma that has progressed after prior chemotherapy and have initiated Ramucirumab treatment. Exclusion Criteria: Received more than 1 line of chemotherapy for advanced gastric or GEJ, or currently participating in any other study.
SponsorsThis trial is sponsored by Eli Lilly.
Interested in Clinical Trial?
Providers Associated With This Trial
- Moh'd Khushman, M.D.Medical Oncologist and HematologistAssistant Professor of Interdisciplinary Clinical Oncology